Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: An Interactive Mobile Care on Self-management Among T2DM with OSA [NA]
A clinical trial is evaluating an interactive mobile self-management care program for people with obstructive sleep apnea and type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM [Phase 4]
Phase 4 clinical trial update evaluating henagliflozin for liver fibrosis in patients with MASLD and type 2 diabetes; the study is currently…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Comparative Evaluation of the Evolution of Arterial and Microcirculatory Endothelial Function in Obese Patients With Type-2 Diabetes Versus Non-diabetic Obese Patients After a First Bariatric Surgery [NA]
This clinical trial compares the evolution of arterial and microcirculatory endothelial function after a first bariatric surgery in obese pa…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Antidiabetic Potential of Galician High-phenolic Extra Virgin Olive Oils in Patients With Type 2 Diabetes Mellitus. [NA]
A completed clinical trial evaluated the antidiabetic potential of Galician high-phenolic extra virgin olive oils in patients with type 2 di…
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Chronic Passive Heating in Individuals With T2DM [NA]
A completed clinical trial evaluating chronic passive heating in individuals with Type 2 diabetes has posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
A prospective, multi-center registry study evaluating the effects of SGLT2 inhibitors on clinical outcomes and left ventricular remodeling i…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: Improving Diabetic Patient Health Through Assistive-Reading Technology [NA]
This completed clinical trial evaluated whether assistive-reading technology improves health knowledge, attitudes, and self-management in ad…
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Mapping Diabetes in Quebec: Validating Medico-administrative Algorithms for Type 1 Diabetes, Type 2 Diabetes and LADA
This study by Universite du Quebec en Outaouais aims to validate medico-administrative data algorithms for identifying and mapping Type 1 di…
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Assessment of Serum Magnesium Level with Diabetic Foot Ulceration in Type II Diabetes Associated with Diabetic Nephropathy Patients
This clinical trial update describes a study assessing serum magnesium levels in adults with type 2 diabetes, diabetic nephropathy, and diab…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: A Clinical Trial to Evaluate the Food Effect of CKD-379 [Phase 1]
A Phase 1 trial evaluating the effect of food on CKD-379 in Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: A Study to Evaluate Effects of KN056 in Healthy Participants [Phase 1]
This update reports the completion of a Phase 1 study evaluating KN056 in healthy participants; Type 2 diabetes mellitus is listed as the co…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Evaluation of Zinc in Patients With Type 2 Diabetes
A clinical trial evaluating zinc supplementation in patients with Type 2 Diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Improving Detection and Evidence-based Care of NAFLD in Latinx and Black Patients With Type 2 Diabetes [NA]
A completed clinical trial update from Duke University examining improved detection and evidence-based care of non-alcoholic fatty liver dis…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Mobile Health Intervention to Reduce Diabetes Disparities in Chinese Americans [NA]
A completed clinical trial evaluated a mobile health intervention designed to reduce diabetes disparities in Chinese Americans with type 2 d…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Exercise Training and Type 2 Diabetes [NA]
An update on a clinical trial studying exercise training in people with type 2 diabetes shows the study has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: FreeStyle Libre Monitoring in T2DM [NA]
A completed clinical trial evaluating FreeStyle Libre glucose monitoring in adults with Type 2 diabetes mellitus. The study was sponsored by…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: STUDIIO-Diabetes Pilot: STUdy of Drug Insurance to Improve Outcomes of Diabetes [NA]
A clinical trial update for STUDIIO-Diabetes Pilot investigating drug insurance to improve outcomes in Type 2 Diabetes Mellitus; the study i…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Hypoglycemia Prevention in High-Risk Type 2 Diabetes Patients [NA]
A Kaiser Permanente-sponsored clinical trial evaluating hypoglycemia prevention in high-risk Type 2 diabetes patients has completed.
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Effects of an Evening PROtein PrEload on Metabolic Health in Night ShIfT Workers (PROPENSITy) [NA]
This clinical trial update describes a study evaluating the metabolic effects of an evening protein preload in night shift workers. The stud…
-
FDA approval · 2024-12-23FDA Approved: LIRAGLUTIDE — Original Application (Hybio Pharmaceutical Co., Ltd. (Pingshan Factory))
FDA approved an original application for liraglutide manufactured by Hybio Pharmaceutical Co., Ltd. (Pingshan Factory).
-
FDA approval · 2024-12-20FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for dapagliflozin and metformin hydrochloride, enabling a fixed-dose combination product for type 2 …
-
FDA approval · 2024-12-20FDA Approved: STEGLUJAN — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for STEGLUJAN (ertugliflozin and sitagliptin) from Merck, indicating an update to its labeling a…
-
FDA approval · 2024-12-20FDA Approved: SEGLUROMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Segluromet (ertugliflozin and metformin hydrochloride) by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial is evaluating SGLT2 inhibitors as first-line therapy to prevent renal decline in adults with Type 2 diabetes; the s…
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Ertugliflozin: Cardioprotective Effects on Epicardial Fat [EARLY_Phase 1]
An early Phase 1 trial from Stanford examines whether ertugliflozin has cardioprotective effects on epicardial fat. The study status is comp…